TY - JOUR T1 - Evaluating the Sensitivity of SARS-CoV-2 Infection Rates on College Campuses to Wastewater Surveillance JF - medRxiv DO - 10.1101/2020.10.09.20210245 SP - 2020.10.09.20210245 AU - Tony E. Wong AU - George M. Thurston AU - Nathaniel Barlow AU - Nathan Cahill AU - Lucia Carichino AU - Kara Maki AU - David Ross AU - Jennifer Schneider Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/10/11/2020.10.09.20210245.abstract N2 - As college campuses reopen, we are in the midst of a large-scale experiment on the efficacy of various strategies to contain the SARS-CoV-2 virus. Traditional individual surveillance testing via nasal swabs and/or saliva is among the measures that colleges are pursuing to reduce the spread of the virus on campus. Additionally, some colleges are testing wastewater on their campuses for signs of infection, which can provide an early warning signal for campuses to locate COVID-positive individuals. However, a representation of wastewater surveillance has not yet been incorporated into epidemiological models for college campuses, nor has the efficacy of wastewater screening been evaluated relative to traditional individual surveillance testing, within the structure of these models. Here, we implement a new model component for wastewater surveillance within an established epidemiological model for college campuses. We use a hypothetical residential university to evaluate the efficacy of wastewater surveillance to maintain low infection rates. We find that wastewater sampling with a 1-day lag to initiate individual screening tests, plus completing the subsequent tests within a 4-day period can keep overall infections within 5% of the infection rates seen with traditional individual surveillance testing. Our results also indicate that wastewater surveillance can be an effective way to dramatically reduce the number of false positive cases by identifying subpopulations for surveillance testing where infectious individuals are more likely to be found. Through a Monte Carlo risk analysis, we find that surveillance testing that relies solely on wastewater sampling can be fragile against scenarios with high viral reproductive numbers and high rates of infection of campus community members by outside sources. These results point to the practical importance of additional surveillance measures to limit the spread of the virus on campus and the necessity of a proactive response to the initial signs of outbreak.Author Summary College campuses have employed a variety of measures to keep their communities safe amid the SARS-CoV-2 pandemic. Many colleges are implementing surveillance testing programs wherein students are randomly selected to be tested for SARS-CoV-2. These strategies aim to manage the number of infections among the student population by isolating infected individuals. Some colleges are monitoring wastewater on their campuses for signs of the virus, which has been found to be capable of detecting viral RNA. If a wastewater sample shows signs of viral RNA, then screening tests are administered to the individuals who live or work in the buildings that contribute to the sewer in question. We present a model for such wastewater surveillance within a larger model for the spread of SARS-CoV-2 on a college campus. We show that wastewater surveillance can reduce the number of false positive cases and the associated disruptions to student life, while maintaining similar overall numbers of infections. However, we find that surveillance testing strategies that rely solely on wastewater sampling may be less effective if the local transmission rate of the virus is high, or if the rate of infection of members of the campus community by outside sources is high.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors received no specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll model codes, analysis codes, input files, and output data sets are freely available at https://github.com/tonyewong/SEIR-WW under the MIT open-source license. https://github.com/tonyewong/SEIR-WW ER -